Insider · CIK 0002015142
Tessa Cigler
Files at ATOS (ATOSSA THERAPEUTICS, INC.). First filing -, latest -.
Tessa Cigler files SEC Form 4 as director at ATOS (ATOSSA THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tessa Cigler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 10,000 | May 14, 2026 |
| May 15, 2025 | ATOS ATOSSA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +125,000 | $0.00 | $0 | 125,000 | May 16, 2025 |
Questions about Tessa Cigler
Answered from the filings on this page, as of the latest one.
Is Tessa Cigler buying or selling?
Tessa Cigler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tessa Cigler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tessa Cigler has 0.
Where does Tessa Cigler file Form 4?
Tessa Cigler has filed Form 4 at ATOS (ATOSSA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.